Finfeed, page-19

I am a long term investor in mxc. My goals are obviously not aligned with some on mxc threads. Some of who make me giggle. The focus on the share price retreating is curios. You see if your focus is the last few months it clouds the bigger picture. A long term play shows a successful rise in share price and a potential accumulation phase currently transpiring.
If you are trying to predict when the next rise is going to occur you obviously need to do your research, most importantly try and discover any potential news events that will re-rate the share price.
To borrow from rumsfield “there are known knowns.” We know GMP certification is pending, we know that cannepil follows and we know the Australian license is pending.
But there is also the “known unknowns” this finfeed article provides us with a glimpse into some of those:

“MGC Pharma is a global biopharma company with operations in Europe, Australasia and soon North America,” the unknown is the soon to be North American operation. Is it a partnership/ an acquisition/a merger and where is the money coming from for this? A theory I have I will elaborate on...

“Firstly, MGC Pharmaceuticals, which focuses on the research and development of medicines to treat conditions such as cancer” cancer has been more frequently mentioned in their correspondence, this is not by chance...but it is unknown what the medicines are...

“all that being said, at MGC, our core business is pharmaceuticals,” pharmaceutical not Derma. It is clear with the lack of advertising that they are not focusing primarily on this side of the business. Why do it then? What value does it have for the company? If you are trying to drive sales you spend on advertising. So unknown to us is why? Well my theory is the value lies in what other companies view it’s worth. A high quality product and production line already set up and we just need to advertise? Yes please here is 10-20 million which can be used for...

“This, in combination with our global vision of holding a multi-pronged cultivation pipeline in Europe, Australasia and North America,” operations in Australia and North America

So those of you looking for the potential upcoming news events to re-rate the SP. well Roby lead you to the water but he can’t make you drink. IMO DYOR